Viewing Study NCT00100750


Ignite Creation Date: 2025-12-24 @ 5:18 PM
Ignite Modification Date: 2026-02-01 @ 11:47 AM
Study NCT ID: NCT00100750
Status: COMPLETED
Last Update Posted: 2015-01-13
First Post: 2005-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module